No Data
No Data
No Data
No Data
No Data
白雲山:2024年第一季度報告
Futu NewsApr 26 05:24 ET · Announcements
Baiyun Mountain (00874): Mingxing Pharmaceutical's dopamine hydrochloride injection obtained approval for drug supplementation
Baiyunshan (00874) announced that recently, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company (hereinafter referred to as...
Zhitong FinanceApr 26 05:24 ET
Baiyun Mountain (00874) plans to renew the employment of Daxin Certified Public Accountants
According to Zhitong Finance App, Baiyunshan (00874) announced that the company plans to renew Daxin Certified Public Accountants (Special General Partnership) as an accounting firm.
Zhitong FinanceApr 26 05:17 ET
Baiyun Mountain (600332.SH): Branch drugs passed generic drug consistency evaluation
Gelonghui, April 22丨Baiyunshan (600332.SH) announced that the company's branch Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical General Factory (“Baiyunshan Pharmaceutical General Factory”) received the “Drug Supplement Application Approval Notice” issued by the State Drug Administration. Cefixime tablets have passed the consistent evaluation of the quality and efficacy of generic drugs.
Gelonghui FinanceApr 22 05:03 ET
Returns On Capital At Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Have Stalled
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world, we'd like to see a company investing more capital into its business and ideally t
Simply Wall StApr 21 20:52 ET
白雲山:2023年年報
Futu NewsApr 19 05:16 ET · Announcements
No Data
No Data